Update on Mechanical Circulatory Support

Suzanne Bennett; Lauren Sutherland; Promise Ariyo; Frank M O'Connell

doi:10.1016/j.anclin.2022.08.019

Update on Mechanical Circulatory Support

Anesthesiol Clin. 2023 Mar;41(1):79-102. doi: 10.1016/j.anclin.2022.08.019.

Authors

Suzanne Bennett¹, Lauren Sutherland², Promise Ariyo³, Frank M O'Connell⁴

Affiliations

¹ Department of Anesthesiology, University of Cincinnati College of Medicine, 2139 Albert Sabin Way, Cincinnati, OH 45267-0531, USA. Electronic address: suzanne.bennett@uc.edu.
² Columbia University Irving Medical Center, 622 W 168(th) Street, New York, NY 10032, USA.
³ Johns Hopkins University, 1800 Orleans Street, Baltimore, MD 21287, USA.
⁴ Anesthesiology, Atlanticare Regional Medical Center, 65 W Jimmie Leeds Road, Pomona, NJ 08240, USA.

PMID: 36872008
DOI: 10.1016/j.anclin.2022.08.019

Abstract

Mechanical circulatory support (MCS) devices provide temporary or intermediate- to long-term support for acute cardiopulmonary support. In the last 20 to 30 years, tremendous growth in MCS device usage has been seen. These devices offer support for isolated respiratory failure, isolated cardiac failure, or both. Initiation of MCS devices requires the input from multidisciplinary teams using patient factors and institutional resources to guide decision making, along with a planned "exit strategy" for bridge to decision, bridge to transplant, bridge to recovery, or as destination therapy. Important considerations for MCS use include patient selection, cannulation/insertion strategies, and complications of each device.

Keywords: Extracorporeal membrane oxygenation; Impella; Intra-aortic balloon pump; Left ventricular assist device; Mechanical circulatory devices; Venoarterial extracorporeal life support; Venovenous extracorporeal life support.

Publication types

Review

MeSH terms

Cognition*
Heart Failure*
Humans
Patient Selection